Skip to main content
Caplight Logo









DoseSpot

DoseSpot

Private
Dedham, MassachusettsHealthcare & Life Scienceshttps://dosespot.com/

Last Round

M&A

Mar 2, 2026

Total Funding Raised

$25,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DoseSpot is a healthcare technology company that provides e-prescribing, insurance verification, and revenue cycle management software solutions for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Vertical SaaS, Telemedicine, Compliance

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

ePrescribingelectronic prescribingelectronic prescribing of controlled substancese-prescribing APIEPCSelectronic prior authorizationePAEHR integrationreal-time prescription benefitRTPBprescription softwarehealthtech APItelehealth softwareembedded UIdigital health infrastructuree-prescribing widget

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DoseSpot Comparables

Compare DoseSpot with similar companies based on industry and business-model similarity.

DoseSpot comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MDToolbox
83%
D.A.W. Systems, Inc.
79%
Photon Health
79%

DoseSpot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMar 2, 2026
Growth EquityJan 26, 2022
GrantMay 1, 2010

Key People

Founding team and executive leadership

Tosin Adesegha

Chief Financial Officer

Executive Team

Julian Herbert

Chief Product Officer

Executive Team

DoseSpot Investors

Notable investors and investment history

DoseSpot investors
InvestorRounds
Providence Strategic GrowthM&A, Growth Equity
UPMC EnterprisesM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Funding round led by Bain Capital Tech Opportunities.

  • Jan 26, 2022

    Providence Strategic Growth led the round.

DoseSpot Filings

Explore SEC and related filing metadata, where available.

DoseSpot filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DoseSpot's valuation, stock price, and market status.

Is DoseSpot a public or private company?

DoseSpot is a private company.

What is the current stock price of DoseSpot?

DoseSpot is a private company with no public stock price. No recent secondary market data is available.

How much is DoseSpot worth (valuation)?

Valuation information for DoseSpot is not publicly available.

Can I buy DoseSpot stock?

DoseSpot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DoseSpot's last funding round?

DoseSpot's most recent funding round was M&A on March 2, 2026.

Who are the main investors in DoseSpot?

Key investors in DoseSpot include Providence Strategic Growth.

Will DoseSpot IPO soon?

No public IPO plans have been announced for DoseSpot.

How can I track DoseSpot secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DoseSpot's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDedham, Massachusetts
Employee Range51
Year Founded2009
Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?